UNK HIP ACETABULAR CONSTRUCT P
Report
- Report Number
- 1818910-2026-05759
- Event Type
- Injury
- Date Received
- April 2, 2026
- Date of Event
- October 14, 2011
- Manufacturer
- DEPUY ORTHOPAEDICS INC US
- Product Code
- LZO
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
PRODUCT COMPLAINT # (B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803 (AND/OR PART 4, AS APPLICABLE). THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY DEPUY SYNTHES, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. D4: UDI: AS THE CATALOG/MODEL NUMBER WAS NOT PROVIDED, THE (01) GTIN IS NOT AVAILABLE.
PRODUCT COMPLAINT #(B)(4). INVESTIGATION SUMMARY: NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. THIS COMPLAINT WAS OPENED TO DOCUMENT COMPLAINTS DERIVED THROUGH A JOURNAL ARTICLE REVIEW. FOLLOW-UPS WERE DONE TO TRY AND OBTAIN ADDITIONAL INFORMATION FROM THE AUTHOR OF THE JOURNAL ARTICLE. NO FURTHER INFORMATION WAS RECEIVED. AS PART OF OUR COMPANY QUALITY SYSTEM PROCESS, ALL DEVICES ARE MANUFACTURED, INSPECTED, AND DISTRIBUTED TO APPROVED SPECIFICATIONS. ADDITIONAL COMPLAINT INFORMATION MONITORING FOR POTENTIAL SAFETY SIGNALS WILL BE CONDUCTED THROUGH COMPLAINT TRENDING AS PART OF THE POST-MARKET SURVEILLANCE. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE HISTORY LOT: THE DEVICE LOT NUMBER IS UNKNOWN, THEREFORE A DEVICE HISTORY REVIEW COULD NOT BE PERFORMED. IF THE LOT/SERIAL NUMBER BECOMES AVAILABLE, THE RECORD WILL BE RE-ASSESSED.
THIS COMPLAINT IS FROM A LITERATURE SOURCE. THE FOLLOWING LITERATURE CITE HAS BEEN REVIEWED: TAUNTON MJ, FEHRING TK, EDWARDS P, BERNASEK T, HOLT GE, CHRISTIE MJ. PELVIC DISCONTINUITY TREATED WITH CUSTOM TRIFLANGE COMPONENT: A RELIABLE OPTION. CLIN ORTHOP RELAT RES. 2012 FEB;470(2):428-34. DOI: 10.1007/S11999-011-2126-1. PMID: 21997785; PMCID: PMC3254733. OBJECTIVE/METHODS/STUDY DATA: THE AIM OF THIS STUDY IS TO DETERMINE REVISION AND OVERALL SURVIVAL RATES, (2) DISCONTINUITY HEALING RATE, AND HARRIS HIP SCORE (HHS) AFTER TREATMENT OF PELVIC DISCONTINUITY WITH A CUSTOM TRIFLANGE ACETABULAR COMPONENT AND THE COST OF THIS RECONSTRUCTIVE OPERATION COMPARED TO OTHER CONSTRUCTS. A TOTAL OF 57 PATIENTS (51 WOMEN AND SIX MEN) WITH PELVIC DISCONTINUITY TREATED WITH REVISION THA USING A CUSTOM TRIFLANGE ACETABULAR COMPONENT (PINNACLETM TRIFLANGE ACETABULAR SYSTEM (DEPUY ORTHOPAEDICS, INC, WARSAW, IN, USA). THE MINIMUM FOLLOWUP WAS 24 MONTHS (AVERAGE, 65 MONTHS; RANGE, 24¿215 MONTHS). LOT, MODEL AND CATALOG NUMBER ARE NOT AVAILABLE, BUT THE SUSPECTED DEPUY SYNTHES DEVICE(S) POSSIBLY ASSOCIATED WITH REPORTED ADVERSE EVENTS: PINNACLE TRIFLANGE ACETABULAR SYSTEM ADVERSE EVENT(S) AND PROVIDED INTERVENTIONS POSSIBLY ASSOCIATED WITH UNK HIP ACETABULAR CONSTRUCT PINNACLE (QTY 35). N=20; HAD REVISION FOR ANY REASON. N=2; DEEP INFECTION - RESECTION OF THE ACETABULAR COMPONENT. N=2; SUPERFICIAL SEROMAS - REOPERATION. N=1; SCIATIC PALSY - NERVE EXPLORATION. N=10; NO OBVIOUS HEALING OF THE DISCONTINUITY . ADVERSE EVENT(S) AND PROVIDED INTERVENTIONS POSSIBLY ASSOCIATED WITH UNK HIP ACETABULAR CUP PINNACLE (QTY 13). N=1; ASEPTIC LOOSENING (11 YEARS POST SURGERY) - REVISION. N=9; MIGRATION OF AT LEAST A PART OF THE TRIFLANGE ACETABULAR COMPONENT. N=3; ISCHIAL SCREW MIGRATION - NO INTERVENTION REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 170519 | UNK HIP ACETABULAR CONSTRUCT P | PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER | LZO | DEPUY ORTHOPAEDICS INC US |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention |